Boston Scientific, Medtronic announce settlement of patent litigations

Boston Scientific Corporation and Medtronic, Inc., recently announced that they have entered into an agreement to settle three patent lawsuits between the two companies. These lawsuits involved Boston Scientific's Keith patents and Medtronic's Enger patents and related to rapid exchange coronary stent delivery systems and rapid exchange balloon dilatation catheters of both parties. Terms of the agreement were not disclosed.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices. The company's products are used in a broad range of interventional medical specialties.

Medtronic, Inc., headquartered in Minneapolis, is the world's leading medical technology company, providing lifelong solutions for people with chronic disease. Its Internet address is www.medtronic.com.

Source: Medtronic, Inc.

Subscribe to our free e-mail newsletter.

Click for a free Buyer's Guide listing.